These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 15797746

  • 1. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
    Lijkwan MA, Cooke DT, Martens JM, Kown MH, Murata S, Peterson SH, Hoyt EG, Robbins RC.
    J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M, Mokhtari GK, Balsam LB, Cooke DT, Kofidis T, Zwierzchonievska M, Robbins RC.
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of graft coronary arteriosclerosis after heart transplantation.
    Soukiasian HJ, Czer LS, Wang HM, Luthringer D, Wang C, Kamlot A, Quartel A, Trento A.
    Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
    [Abstract] [Full Text] [Related]

  • 4. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G, Kaski JC, Tousoulis D, Kiowski W, Turina M, Follath F, Gallino A.
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC, Fisher RA, Cohen DS, Tawes JW, Grimes MM.
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [Abstract] [Full Text] [Related]

  • 7. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J.
    Transplantation; 2003 Apr 15; 75(7):945-52. PubMed ID: 12698078
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK, Lemström KB, Häyry PJ.
    Am J Pathol; 1995 Apr 15; 146(4):972-80. PubMed ID: 7536397
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL, Geraghty J, Steele DM, Kennedy E, Hullett DA, Sollinger HW.
    Transplantation; 1995 Nov 15; 60(9):993-8. PubMed ID: 7491707
    [Abstract] [Full Text] [Related]

  • 11. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.
    Hisatomi K, Isomura T, Ohashi M, Tamehiro K, Sato T, Tayama E, Ohishi K, Kohjiro M.
    J Heart Lung Transplant; 1995 Nov 15; 14(1 Pt 1):113-8. PubMed ID: 7537098
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease.
    Balsam LB, Mokhtari GK, Jones S, Peterson S, Hoyt EG, Kofidis T, Tanaka M, Cooke DT, Robbins RC.
    J Heart Lung Transplant; 2005 Jul 15; 24(7):827-32. PubMed ID: 15982609
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor.
    Paul LC, Davidoff A, Benediktsson H.
    Transplantation; 1994 Jun 27; 57(12):1767-72. PubMed ID: 7517077
    [Abstract] [Full Text] [Related]

  • 20. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T, Yamane M, Sano Y, Aoe M, Date H, Shimizu N.
    Transpl Immunol; 2007 Jun 27; 17(4):249-54. PubMed ID: 17493527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.